Description

Learning Objectives:

• List the new developments in long acting reversible methods
• Describe the new combined hormonal and barrier methods under development
• Explain how these new methods may help reduce unintended pregnancies

Speaker(s):

• Anita Nelson, MD

Disclosures

• Anita Nelson, MD:

  Disclosure:

  Agile Pharmaceutical, ContraMed, Merck, NIH
  Allergan, Agile, Aspen Pharma, Bayer, Merck
  Allergan, Agile, Bayer, ContraMed
  Female Health, Merck, MicroCHIPS Biotech
  PharmaNest
  

  Relationship:

  Research (Grants)
  Speakers Bureau/Honoraria
  Consultant/Advisory Board/Honoraria
  Consultant/Advisory Board/Honoraria
  Consultant/Advisory Board/Honoraria